Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov:14 Suppl 5:33-36.
doi: 10.1111/ajco.13056.

Adjuvant therapy after nephrectomy for renal cell carcinoma

Alain Ravaud  1
Affiliations
Review

Adjuvant therapy after nephrectomy for renal cell carcinoma

Alain Ravaud. Asia Pac J Clin Oncol. 2018 Nov.

Abstract

Adjuvant treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor in renal cell carcinoma after nephrectomy has been reported through three clinical trials: S-TRAC, ASSURE and PROTECT. Only S-TRAC has been significantly positive on primary end-point disease-free survival under sunitinib compared to placebo, whereas ASSURE and PROTECT did not show any gain under sunitinib, sorafenib or pazopanib. This short review presents the differences between the trials and provides hypotheses on why S-TRAC may have been positive.

Keywords: S-TRAC; adjuvant; renal cell carcinoma; sunitinib.

PubMed Disclaimer

Similar articles

See all similar articles

MeSH terms

LinkOut - more resources